ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/21 | 3,380 | 3,400 | 3,330 | 3,330 | -70 | -2.1% | 62,900 |
| 2024/06/20 | 3,380 | 3,400 | 3,355 | 3,400 | +25 | +0.7% | 29,400 |
| 2024/06/19 | 3,445 | 3,445 | 3,370 | 3,375 | -35 | -1% | 30,400 |
| 2024/06/18 | 3,405 | 3,435 | 3,385 | 3,410 | +5 | +0.1% | 18,100 |
| 2024/06/17 | 3,450 | 3,450 | 3,385 | 3,405 | -45 | -1.3% | 36,200 |
| 2024/06/14 | 3,470 | 3,470 | 3,430 | 3,450 | -5 | -0.1% | 9,900 |
| 2024/06/13 | 3,485 | 3,485 | 3,430 | 3,455 | -30 | -0.9% | 31,800 |
| 2024/06/12 | 3,515 | 3,520 | 3,480 | 3,485 | -15 | -0.4% | 24,400 |
| 2024/06/11 | 3,515 | 3,540 | 3,500 | 3,500 | -15 | -0.4% | 23,100 |
| 2024/06/10 | 3,515 | 3,520 | 3,500 | 3,515 | ±0 | ±0% | 24,500 |
| 2024/06/07 | 3,515 | 3,515 | 3,485 | 3,515 | ±0 | ±0% | 21,300 |
| 2024/06/06 | 3,485 | 3,515 | 3,470 | 3,515 | +40 | +1.2% | 38,400 |
| 2024/06/05 | 3,480 | 3,490 | 3,465 | 3,475 | ±0 | ±0% | 24,200 |
| 2024/06/04 | 3,480 | 3,490 | 3,460 | 3,475 | ±0 | ±0% | 26,000 |
| 2024/06/03 | 3,465 | 3,485 | 3,440 | 3,475 | +35 | +1% | 37,100 |
| 2024/05/31 | 3,405 | 3,460 | 3,405 | 3,440 | +20 | +0.6% | 38,700 |
| 2024/05/30 | 3,415 | 3,425 | 3,380 | 3,420 | -5 | -0.1% | 33,800 |
| 2024/05/29 | 3,435 | 3,435 | 3,410 | 3,425 | -10 | -0.3% | 12,900 |
| 2024/05/28 | 3,400 | 3,440 | 3,400 | 3,435 | +15 | +0.4% | 18,600 |
| 2024/05/27 | 3,400 | 3,430 | 3,390 | 3,420 | +30 | +0.9% | 13,900 |
| 2024/05/24 | 3,385 | 3,415 | 3,375 | 3,390 | -20 | -0.6% | 12,100 |
| 2024/05/23 | 3,420 | 3,430 | 3,390 | 3,410 | +20 | +0.6% | 20,100 |
| 2024/05/22 | 3,440 | 3,440 | 3,380 | 3,390 | -30 | -0.9% | 26,700 |
| 2024/05/21 | 3,465 | 3,485 | 3,420 | 3,420 | -40 | -1.2% | 29,300 |
| 2024/05/20 | 3,445 | 3,465 | 3,445 | 3,460 | +20 | +0.6% | 56,700 |
| 2024/05/17 | 3,435 | 3,460 | 3,430 | 3,440 | -5 | -0.1% | 31,300 |
| 2024/05/16 | 3,425 | 3,445 | 3,415 | 3,445 | +20 | +0.6% | 26,500 |
| 2024/05/15 | 3,450 | 3,450 | 3,420 | 3,425 | -25 | -0.7% | 23,300 |
| 2024/05/14 | 3,465 | 3,470 | 3,425 | 3,450 | -15 | -0.4% | 34,200 |
| 2024/05/13 | 3,450 | 3,515 | 3,435 | 3,465 | +45 | +1.3% | 102,100 |
| 2024/05/10 | 3,325 | 3,470 | 3,270 | 3,420 | +115 | +3.5% | 173,600 |
| 2024/05/09 | 3,345 | 3,345 | 3,295 | 3,305 | -40 | -1.2% | 41,100 |
| 2024/05/08 | 3,350 | 3,380 | 3,345 | 3,345 | -20 | -0.6% | 24,400 |
| 2024/05/07 | 3,370 | 3,385 | 3,350 | 3,365 | +5 | +0.1% | 16,500 |
| 2024/05/02 | 3,355 | 3,375 | 3,335 | 3,360 | +5 | +0.1% | 14,800 |
| 2024/05/01 | 3,320 | 3,360 | 3,320 | 3,355 | +25 | +0.8% | 20,100 |
| 2024/04/30 | 3,330 | 3,330 | 3,310 | 3,330 | +25 | +0.8% | 7,300 |
| 2024/04/26 | 3,305 | 3,325 | 3,270 | 3,305 | -15 | -0.5% | 28,700 |
| 2024/04/25 | 3,340 | 3,360 | 3,310 | 3,320 | -15 | -0.4% | 26,900 |
| 2024/04/24 | 3,320 | 3,335 | 3,300 | 3,335 | +30 | +0.9% | 22,900 |
| 2024/04/23 | 3,310 | 3,320 | 3,290 | 3,305 | -5 | -0.2% | 16,900 |
| 2024/04/22 | 3,255 | 3,310 | 3,255 | 3,310 | +70 | +2.2% | 15,900 |
| 2024/04/19 | 3,275 | 3,275 | 3,200 | 3,240 | -30 | -0.9% | 43,900 |
| 2024/04/18 | 3,275 | 3,300 | 3,270 | 3,270 | -5 | -0.2% | 20,600 |
| 2024/04/17 | 3,330 | 3,330 | 3,275 | 3,275 | -45 | -1.4% | 38,100 |
| 2024/04/16 | 3,365 | 3,365 | 3,320 | 3,320 | -50 | -1.5% | 29,200 |
| 2024/04/15 | 3,365 | 3,380 | 3,355 | 3,370 | -15 | -0.4% | 18,200 |
| 2024/04/12 | 3,385 | 3,400 | 3,360 | 3,385 | ±0 | ±0% | 19,000 |
| 2024/04/11 | 3,400 | 3,410 | 3,380 | 3,385 | -35 | -1% | 23,300 |
| 2024/04/10 | 3,405 | 3,445 | 3,390 | 3,420 | +20 | +0.6% | 49,800 |
201～
250
件表示中 / 2279件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 146,300円 | +1.2% | -13.9% | 5.81% | 8.63倍 | 1.61倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ダイト | 201,000円 | +4.5% | -33.7% | 3.48% | 20.25倍 | 0.58倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ヘリオス | 27,800円 | +150.0% | - | 0.00% | - | 13.65倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 扶桑薬 | 224,200円 | +8.3% | +98.1% | 3.66% | 7.37倍 | 0.51倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| アンジェス | 6,300円 | +110.0% | - | 0.00% | - | 10.05倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
市場注目の銘柄
チャート関連のコラム
